Jonathan M. Peacock, President and CEO at Bellerophon Therapeutics, Inc. (BLPH), bought 5,560 shares at $8.69 ($48K) on 2015-05-20, disclosed to the SEC on 2015-05-22.
High-signal trade — passes our conviction filters but the AI narrative is still being generated. Check back shortly.
Nothing distinguishes this filing.
| Filing → |
| BLPH | BUY | 2019-01-25 | $1.0M | — | Filing → |
| BLPH | BUY | 2016-05-18 | $7K | — | Filing → |
| BLPH | BUY | 2015-12-17 | $56K | — | Filing → |